Figure2 (Guanfacine 2figure)
Guanfacine Tablet, Extended Release
Product Images NDC 50090-7644
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 50090-7644). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 3 (Guanfacine 3 Figure)
This text provides information on the drug interaction involving oral Methylphenidate and Lisdexamfetamine Dimesylate. It includes data on fold change in drug pharmacokinetics (PK) and 90% confidence intervals (CI) for parameters such as Cmax (maximum concentration of drug in the blood) and AUC (area under the plasma concentration-time curve). The text mentions the relative change in Cmax and AUC compared to a reference value.*
Figure1 (Guanfacine Figure 1)
Figure 4 (Guanfacine Figure4)
This text appears to be displaying data related to treatment failure over time. The values seem to represent the days taken for treatment failure to occur. It is likely part of a study or analysis on the effectiveness of a treatment or intervention.*
Structure (Guanfacine Str)
Label Image (Lbl500907644)
Not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
